Counseling cancer patients on complementary and alternative medicine: Background, theory, and implementation of nationwide counseling facilities

Strahlentherapie und Onkologie

Volumn 189, Issue 8, 2013, Pages 613-617

  Hubner J ^a   Muenstedt, K ^b   Muecke, R ^c   Micke, O ^d   Stoll, C ^e   Kleeberg, U R ^f   Buentzel, J ^g   Dennert, G ^h   Prott, F J ⁱ  

^a GOETHE UNIVERSITY   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c Department of Internal Medicine and Gastroenterology   (Germany)

^d FRANZISKUS HOSPITAL   (Germany)

^e Clinic Herzoghoehe   (Germany)

^f HOPA   (Germany)

^g Nordhausen Clinic   (Germany)

^h Institute for Transdisciplinary Health Care Research   (Germany)

ⁱ Radiooncology   (Germany)

Author keywords

Complementary therapies; Germany; Guideline; Literature review; Recommendations

Indexed keywords

ALLOPATHY; ALTERNATIVE MEDICINE; ARTICLE; CANCER CENTER; CANCER PATIENT; CANCER THERAPY; DOCTOR PATIENT RELATION; EVIDENCE BASED MEDICINE; HUMAN; PATIENT COUNSELING; PATIENT DECISION MAKING; PATIENT INFORMATION; PATIENT REFERRAL; PATIENT SATISFACTION; QUALITY OF LIFE; REIMBURSEMENT; SOCIAL ASPECT; SOCIAL PSYCHOLOGY;

COMPLEMENTARY THERAPIES; DELIVERY OF HEALTH CARE; DIRECTIVE COUNSELING; GERMANY; HUMANS; MEDICAL ONCOLOGY; MODELS, ORGANIZATIONAL; NEOPLASMS;

EID: 84881224579     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-013-0392-4     Document Type: Article

References (23)

1. Becker-Schiebe M, Mengs U, Schaefer M et al (2011) Topical use of a silymarin-based preparation to prevent radiodermatitis; results of a prospective study in breast cancer patients. Strahlenther Onkol 187(8):485-491
2. Blank E, Willich N, Fietkau R et al (2012) Evaluation of time, attendance of medical staff, and resources during radiotherapy for breast cancer patients; the DEGRO-QUIRO trial. Strahlenther Onkol 188(2):113-119
3. Broom A, Tovey P (2008) The role of the internet in cancer patients' engagement with complementary and alternative treatments. Health (London) 12:139-155
4. Dennert G, Wolf G (2012) Ressourcenorientierte Beratung von Patientinnen und Patienten zur Komplementäronkologie. Ärztliche Psychother Psychosomatische Med 175-180
5. Eder-Czembirek C, Erovic BM, Czembirek C et al (2010) Betulinic acid a radiosensitizer in head and neck squamous cell carcinoma cell lines. Strahlenther Onkol 186(3):143-148
6. Eng J, Ramsum D, Verhoef M et al (2003) A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer. Integr Cancer Ther 2:212-216
7. Ernst E, Resch KL, Mills S et al (1995) Complementary medicine - a definition. Br J Gen Pract 45:506
8. Eschiti VS (2007) Lesson from comparison of CAM use by women with female-specific cancers to others: it's time to focus on interaction risks with CAM therapies. Integr Cancer Ther 6:313-344
9. Frenkel M, Ben-Arye E, Cohen L (2010) Communication in cancer care: discussing complementary and alternative medicine. Integr Cancer Ther 9:177-185
10. Geinitz H, Marten-Mittag B, Schäfer C et al (2012) Patient satisfaction during radiation therapy. Correlates and patient suggestions. Strahlenther Onkol 188(6):492-498
11. Hann D, Allen S, Ciambrone D, Shah A (2006) Use of complementary therapies during chemotherapy: Influence of patients' satisfaction with treatment decision making and the treating oncologist. Integr Cancer Ther 5:224-231
12. Hübner J, Dennert G, Münstedt K (2012) Beratungsangebote zu komplementären und alternative Methoden in der Onkologie. Forum 27:136-139
13. Maskarinec G, Gotay CC, Tatsumura Y et al (2001) Perceived cancer causes: use of complementary and alternative therapy. Cancer Pract 9:183-190
14. Micke O, Bruns F, Glatzel M et al (2009) Predictive factors for the use of complementary and alternative medicine (CAM) in radiation oncology. Eur J Integr Med 1:22-30
15. Molassiotis A, Fernadez-Ortega P, Pud D et al (2005) Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 16:655-663
16. Münstedt K, Harren H, Georgi R von, Hackethal A (2011) Conplementary and alternative medicine: comparison of current knowledge, attitudes and interest among German medical students and doctors. Evid Based Complement Alternat Med. doi: 10.1093/ecam/nen079
17. Robinson A, McGrail MR (2004) Disclosure of CAM use to medical practitioners: a review of qualitative and quantitative studies. Complement Ther Med 12:90-98
18. Saxe GA, Madlensky L, Kealey S et al (2008) Disclosure to physicians of CAM use by breast cancer patients: findings from the Women's Healthy Eating and Living Study. Integr Cancer Ther 7:122-129
19. Schofield P, Diggens J, Charleson C et al (2010) Effectively discussing complementary and alternative medicine in a conventional oncology setting: communication recommendations for clinicians. Patient Educ Couns 79:143-151
20. Shelley BM, Sussman AL, Williams RL et al (2009) They don't ask me so I don't tell them: patient-clinician communication about traditional, complementary, and alternative medicine. Ann Fam Med 7:139-147
21. Singh H, Maskarinec G, Shumay DM (2005) Understanding the motivation for conventional and complementary/alternative medicine use among men with prostate cancer. Integr Cancer Ther 4:187-194
22. Snyder JD for the American College of Physicians Ethics, Professionalism, and Human Rights Committee (2012) American College of Physicians Ethics Manual, 6. Edn. http://www.acponline.org/running-practice/ethics/manual/manual6th.htm Accessed: 17 June 2013
23. Verhoef MJ (2009) Complementary therapies for cancer patients: assessing information use and needs. Chronic Dis Can 29:80-85